Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

A letter from Dr Gunson to Dr Contreras stated that the Department of Health had not asked for any priority to be given to anti-HCV screening and that he would advise Dr Contreras of the financial arrangements to be made as soon as he could.

  • Read more about A letter from Dr Gunson to Dr Contreras stated that the Department of Health had not asked for any priority to be given to anti-HCV screening and that he would advise Dr Contreras of the financial arrangements to be made as soon as he could.

A letter from Jean Harrison to Dr Gunson stated that the earliest the Brentwood RTC could start anti-HCV testing would be 15 April 1991, but the preferred start date would be 1 May 1991 or 1 June 1991.

  • Read more about A letter from Jean Harrison to Dr Gunson stated that the earliest the Brentwood RTC could start anti-HCV testing would be 15 April 1991, but the preferred start date would be 1 May 1991 or 1 June 1991.

A letter from Dr Fraser to Dr Gunson stated that 1 July 1991 would be the most appropriate date to start anti-HCV testing at the Bristol RTC.

  • Read more about A letter from Dr Fraser to Dr Gunson stated that 1 July 1991 would be the most appropriate date to start anti-HCV testing at the Bristol RTC.

A letter from Dr Martlew to Dr Gunson noted that they would prefer to delay the implementation of anti-HCV testing at the Liverpool RTC to 1 August 1991.

  • Read more about A letter from Dr Martlew to Dr Gunson noted that they would prefer to delay the implementation of anti-HCV testing at the Liverpool RTC to 1 August 1991.

A letter from Professor Cash to Dr Gunson noted that a May/June date might be anticipated to commence anti-HCV testing in Scotland.

  • Read more about A letter from Professor Cash to Dr Gunson noted that a May/June date might be anticipated to commence anti-HCV testing in Scotland.

A letter from Dr Fereydoun Ala to Dr Gunson noted that routine testing for HCV in the West Midlands RTC could begin by April 1991.

  • Read more about A letter from Dr Fereydoun Ala to Dr Gunson noted that routine testing for HCV in the West Midlands RTC could begin by April 1991.

A letter from S McDougall to Dr Gunson noted that the commencement of routine anti-HCV testing at the Cambridge RTC was unlikely to start before 1 October 1991.

  • Read more about A letter from S McDougall to Dr Gunson noted that the commencement of routine anti-HCV testing at the Cambridge RTC was unlikely to start before 1 October 1991.

Dr Contreras wrote that, "We are extremely busy with our Business Plans and contracts as well as dealing with the extra workload incurred as a result of the Gulf War and we cannot give anti-HCV screening the priority required by the Department of Health."

  • Read more about Dr Contreras wrote that, "We are extremely busy with our Business Plans and contracts as well as dealing with the extra workload incurred as a result of the Gulf War and we cannot give anti-HCV screening the priority required by the Department of Health."

Arrangements for implementing anti-HCV screening were discussed in detail by the Advisory Committee on Transfusion Transmitted Diseases.

  • Read more about Arrangements for implementing anti-HCV screening were discussed in detail by the Advisory Committee on Transfusion Transmitted Diseases.

Dr Metters reported to the meeting that France, Belgium and Luxembourg had all commenced mandatory screening, while Italy had introduced optional screening.

  • Read more about Dr Metters reported to the meeting that France, Belgium and Luxembourg had all commenced mandatory screening, while Italy had introduced optional screening.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 250
  • Page 251
  • Page 252
  • Page 253
  • Current page 254
  • Page 255
  • Page 256
  • Page 257
  • Page 258
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.